logo
Plus   Neg
Share
Email

AstraZeneca To Sell Rights To Seroquel, Seroquel XR In The US, Canada

AstraZeneca (AZN.L) has agreed to sell the commercial rights to Seroquel and Seroquel XR, used to treat schizophrenia and bipolar disorder, in the US and Canada to Cheplapharm Arzneimittel GmbH. Cheplapharm will make an upfront payment of $35 million to AstraZeneca and may also make future sales-contingent payments of up to $6 million.

Ruud Dobber, Executive Vice President, BioPharmaceuticals Business Unit, said: "This divestment supports our strategy of reducing the number of mature medicines to enable reinvestment in our main therapy areas. Cheplapharm recently agreed to acquire the commercial rights to Seroquel and Seroquel XR in most European markets and Russia from AstraZeneca."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
DMM Vission is recalling five lots of Cleaner Hand Sanitizer due to potential presence of methanol (wood alcohol), the U.S. Food & Drug Administration said in a statement. The company is yet to receive any reports of adverse events involving the product. Facebook Inc. said it will ban ads that seek to delegitimize the Presidential election. The announcement is in line with the social media giant's decision to prohibit ads that make premature declarations of victory as it aims to protect the integrity of the upcoming U.S. 2020 elections. Rob Leathern, Director of Product Management, in a tweet said that these changes apply to ads across Facebook... While reporting financial results for the first quarter of fiscal 2021 on Thursday, Conagra Brands, Inc. (CAG) provided only its adjusted earnings and organic net sales growth guidance for the second quarter of fiscal 2021. The company is still not initiating annual outlook, as is usual, as the impact...
Follow RTT